Cleo Diagnostics Ltd (ASX: COV)
Health Care · Biotechnology · AU
AU$0.31
-1.59% today · -16.2% 1Y
Cleo Diagnostics Ltd (ASX: COV) operates in the Biotechnology industry within the Health Care sector. The company is valued at $29.57M.
Over the last twelve months the share price has lost 16.2%, trading between 0.27 and 0.90.
Tweenvest scores Cleo Diagnostics Ltd across four factors: quality 44/100, value 24/100. Its strongest factor is quality.
COV price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $29.57M
- Revenue (TTM)
- $1.19M
- P/E
- —
- EPS
- -0.04
- Dividend yield
- —
- Beta (5Y)
- 0.52
- 52-week high
- AU$0.90
- 52-week low
- AU$0.27
- Avg volume (3M)
- —
- Shares outstanding
- 137.11M
- Employees
- —
- Next earnings
- —
About Cleo Diagnostics Ltd
Cleo Diagnostics Ltd, a biotechnology company, engages in the development and patent of a blood test for the detection of ovarian cancer in Australia. The company offers CleoDX pre-surgical triage tests which measures a combination of five biomarkers in serum to provide an accurate determination of malignancy risk prior to surgical referral. It also focuses on developing and testing intellectual property, testing the IP, and securing patents. Cleo Diagnostics Ltd was incorporated in 2021 and is based in Melbourne, Australia.
- ISIN
- AU0000288045
- Founded
- 2021
- Listed since
- Aug 22, 2023
- Exchange
- Australian Securities Exchange
- Currency
- AUD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Immunotech Biopharm LtdSEHK: 6978 | $30.29M | HK$0.39 | -4.94% |
| BriaCell Therapeutics Corp.TSX: BCT | $30.01M | CA$4.88 | -13.01% |
| Poltreg S.A.WSE: PTG | $29.79M | zł19.55 | +0.26% |
| Nicox S.A.ENXTPA: ALCOX | $29.74M | €0.30 | -2.91% |
| Parataxis Korea, Inc.KOSDAQ: A288330 | $29.36M | ₩— | — |
| Medicenna Therapeutics Corp.TSX: MDNA | $29.36M | CA$0.45 | +3.45% |
| Quratis Inc.KOSDAQ: A348080 | $29.12M | ₩3,310.00 | -11.50% |
| Microbix Biosystems Inc.TSX: MBX | $29.05M | CA$0.30 | -3.23% |
Figures last refreshed Oct 18, 2026.